/
/
/

Bacil Pharma Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%

Share Price Live Stats

Empty box

No results found

Share Market Cap & Key Ratios Overview

Empty box

No results found

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Empty box

No results found

Key Highlights of Bacil Pharma Ltd’s P&L

In 2025-03-31, Bacil Pharma Ltd reported total revenue of ₹0 crore, compared with ₹0 crore in 2024-03-31, reflecting Bacil Pharma Ltd turnover.

Depreciation was ₹7000 crore and finance costs were ₹0 crore in 2025-03-31

Profit Before Tax (PBT) has been ₹40.76Lakh in 2025-03-31 as compared to ₹-₹5.91Lakh in 2024-03-31.

Net Profit (PAT) was ₹40.42Lakh in 2025-03-31 compared with ₹-₹5.91Lakh in 2024-03-31.

Earnings per share (EPS) were ₹0.30 in 2025-03-31, compared with ₹-0.10 in 2024-03-31.